Myth: Alternative nicotine products are as dangerous as smoking: Difference between revisions
Jump to navigation
Jump to search
Line 255: | Line 255: | ||
===2020: Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months=== | ===2020: Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months=== | ||
Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. Moreover, participants in this group [nicotine e-cigarettes] showed the lowest level of exhaled carbon monoxide, and the lowest level of dependence compared to the nicotine-free e-cigarette and control conditions. | Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. Moreover, participants in this group [nicotine e-cigarettes] showed the lowest level of exhaled carbon monoxide, and the lowest level of dependence compared to the nicotine-free e-cigarette and control conditions. | ||
===2020: [https://www.nber.org/papers/w27507 E-Cigarettes and Respiratory Disease: A Replication, Extension, and Future Directions]=== | |||
*The statistical associations between e-cigarette use and respiratory disease are driven by e-cigarette users who are also current or former smokers of combustible tobacco. | |||
*A striking feature of the data is that almost all e-cigarette users were either current or former smokers of combustible tobacco. | |||
*Among respondents who had never smoked combustible tobacco, we find no evidence that current or former e-cigarette use is associated with respiratory disease. | |||
*[https://www.nber.org/system/files/working_papers/w27507/w27507.pdf PDF] | |||
*Citation: E-Cigarettes and Respiratory Disease: A Replication, Extension, and Future Directions, Donald S. Kenkel, Alan D. Mathios, and Hua Wang, NBER Working Paper No. 27507, July 2020, JEL No. I12 | |||
===2020: [https://academic.oup.com/ntr/article/22/Supplement_1/S54/5893624 Exclusive e-cigarette users report lower levels of respiratory symptoms relative to dual e-cigarette and cigarette users]=== | ===2020: [https://academic.oup.com/ntr/article/22/Supplement_1/S54/5893624 Exclusive e-cigarette users report lower levels of respiratory symptoms relative to dual e-cigarette and cigarette users]=== |